|
ZNF20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.77149997080551E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.06700000133276E-08 |
| Normal-vs-Stage2 |
1.412270E-04 |
| Normal-vs-Stage3 |
4.35899982775823E-10 |
| Normal-vs-Stage4 |
8.98781049585295E-12 |
| Stage1-vs-Stage2 |
3.764800E-01 |
| Stage1-vs-Stage3 |
1.422160E-02 |
| Stage1-vs-Stage4 |
3.78629999999713E-05 |
| Stage2-vs-Stage3 |
2.787700E-02 |
| Stage2-vs-Stage4 |
1.563400E-03 |
| Stage3-vs-Stage4 |
1.117550E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.36440000911387E-09 |
| Normal-vs-AfricanAmerican |
1.522030E-03 |
| Normal-vs-Asian |
1.71670999999929E-05 |
| Caucasian-vs-AfricanAmerican |
4.207600E-01 |
| Caucasian-vs-Asian |
1.042840E-01 |
| AfricanAmerican-vs-Asian |
9.480600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.50150000397676E-08 |
| Normal-vs-Female |
6.12420003598402E-09 |
| Male-vs-Female |
3.758000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.37379999598508E-08 |
| Normal-vs-Age(41-60Yrs) |
4.10070000178564E-08 |
| Normal-vs-Age(61-80Yrs) |
9.16249998095253E-09 |
| Normal-vs-Age(81-100Yrs) |
2.749600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.352800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.324600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.394600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.210000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.711200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.320200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.54887999999076E-05 |
| Classical-VS-Follicular |
2.348300E-02 |
| Classical-VS-Other |
8.896400E-01 |
| Classical-VS-Normal |
2.74479999839983E-08 |
| Tall-VS-Follicular |
1.30350000016044E-07 |
| Tall-VS-Other |
2.697200E-01 |
| Tall-VS-Normal |
2.82773804372027E-12 |
| Follicular-VS-Other |
4.140000E-01 |
| Follicular-VS-Normal |
3.68570000000012E-05 |
| Other-VS-Normal |
1.780090E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.89970000011408E-07 |
| Normal-vs-N1 |
2.22940554905904E-11 |
| N0-vs-N1 |
1.954460E-04 |
|
|
